Status:
RECRUITING
Deep Learning Diagnostic and Risk-stratification for IPF and COPD
Lead Sponsor:
Pediatric Clinical Research Platform
Collaborating Sponsors:
University Hospital, Geneva
Swiss Federal Institute of Technology
Conditions:
Lung; Disease, Interstitial, With Fibrosis
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
Idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP), and chronic obstructive pulmonary disease (COPD) are severe, progressive, irreversibly incapacitating pulmonary disorde...
Detailed Description
Aim: To develop and determine the predictive power of an AI (deep learning) algorithm in identifying the acoustic and LUS signatures of IPF, NSIP and COPD in an adult population and discriminating the...
Eligibility Criteria
Inclusion
- Written informed consent
- age \> 18 years old.
- patients with already-diagnosed IPF (group 1) prior to the consultation (index) date.
- patients with already-diagnosed NSIP (group 2) prior to the consultation (index) date.
- patients with already-diagnosed COPD (group 3) prior to the consultation (index) date.
- Control subjects must be followed-up at the pulmonology outpatient clinic for:
- obstructive sleep apnoea.
- occupational lung diseases (miners, chemical workers, etc.).
- pulmonary nodules (considered benign after 2 years).
Exclusion
- patients who cannot be mobilized for posterior auscultation.
- patients known for severe cardiovascular disease with pulmonary repercussion.
- patients known for a concurrent, acute, infectious pulmonary disease (e.g., pneumonia, bronchitis).
- patients known for asthma.
- patients known or suspected of immunodeficiency, alpha-1-antitrypsin deficit, and or under immunotherapy.
- patients with physical inability to follow procedures.
- patients with inability to give informed consent.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05318599
Start Date
April 1 2023
End Date
October 31 2024
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier du Valais Romand
Sion, Valais, Switzerland, 1951